Zacks: Analysts Anticipate HCA Healthcare Inc (NYSE:HCA) to Announce $3.06 EPS

Equities analysts expect HCA Healthcare Inc (NYSE:HCA) to report earnings per share of $3.06 for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have issued estimates for HCA Healthcare’s earnings. The highest EPS estimate is $3.19 and the lowest is $2.96. HCA Healthcare posted earnings of $2.99 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 2.3%. The business is scheduled to report its next quarterly earnings report on Tuesday, February 4th.

On average, analysts expect that HCA Healthcare will report full-year earnings of $10.51 per share for the current financial year, with EPS estimates ranging from $10.41 to $10.60. For the next year, analysts anticipate that the business will report earnings of $11.63 per share, with EPS estimates ranging from $11.39 to $11.85. Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that cover HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The firm had revenue of $12.69 billion for the quarter, compared to analysts’ expectations of $12.48 billion. During the same period last year, the firm earned $2.16 earnings per share. The business’s revenue for the quarter was up 10.9% on a year-over-year basis.

HCA has been the topic of several recent research reports. Barclays raised their price target on HCA Healthcare from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Bank of America raised HCA Healthcare from an “underperform” rating to a “neutral” rating and increased their target price for the company from $130.00 to $137.00 in a research note on Friday, September 6th. Stephens set a $150.00 target price on HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, ValuEngine upgraded HCA Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $155.69.

In other HCA Healthcare news, insider Jon M. Foster sold 19,477 shares of HCA Healthcare stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $132.35, for a total value of $2,577,780.95. Following the sale, the insider now owns 10,015 shares of the company’s stock, valued at approximately $1,325,485.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Deborah M. Reiner sold 749 shares of HCA Healthcare stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $136.67, for a total value of $102,365.83. Following the completion of the sale, the senior vice president now directly owns 8,237 shares in the company, valued at approximately $1,125,750.79. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,571 shares of company stock valued at $5,431,851. Company insiders own 2.70% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Penserra Capital Management LLC acquired a new position in HCA Healthcare during the third quarter worth $26,000. Westside Investment Management Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $34,000. Doyle Wealth Management acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $34,000. Prime Capital Investment Advisors LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Finally, North Star Investment Management Corp. bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $42,000. Institutional investors and hedge funds own 69.40% of the company’s stock.

Shares of HCA stock traded up $2.71 during trading hours on Wednesday, reaching $140.88. The company had a trading volume of 684,330 shares, compared to its average volume of 1,377,894. The company has a 50 day moving average of $133.23 and a 200 day moving average of $129.08. The firm has a market cap of $47.03 billion, a price-to-earnings ratio of 14.42, a P/E/G ratio of 1.17 and a beta of 0.91. HCA Healthcare has a 1-year low of $110.31 and a 1-year high of $147.42.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 2nd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.60 annualized dividend and a yield of 1.14%. HCA Healthcare’s dividend payout ratio is currently 16.38%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: What is a blue-chip stock?

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit